Showing results (391-400 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|May 27, 1999
Economic impact of aminoglycoside toxicity and its prevention through therapeutic drug monitoringR L Slaughter, D M CappellettyPharmacoeconomics|May 27, 1999
Cost effectiveness of fluvoxamine in the treatment of recurrent depression in FranceM Nuijten, L Hadjadjeba, C Evans, et al.Pharmacoeconomics|May 27, 1999
A review of quality of life in Alzheimer's disease. Part 1: Issues in assessing disease impactM D Walker, S S Salek, A J BayerPharmacoeconomics|May 27, 1999
Urge incontinence. Quality of life and patients' valuation of symptom reductionR M O'Conor, M Johannesson, S L Hass, et al.Pharmacoeconomics|May 27, 1999
Economic evaluation of nimesulide versus diclofenac in the treatment of osteoarthritis in GreeceL Liaropoulos, M Spinthouri, T Ignatiades, et al.Pharmacoeconomics|May 27, 1999
Evaluating Health-related quality-of-life outcomes in patients with congestive heart failure. A review of recent randomised controlled trialsN K Leidy, A M Rentz, T M ZyczynskiPharmacoeconomics|May 27, 1999
Cost-benefit analysis of Haemophilus influenzae type b vaccination in children in SpainF J Jiménez, P Guallar-Castillón, C Rubio Terrés, et al.Pharmacoeconomics|October 5, 1994
Expert systems. Assisting formulary decision making in the ambulatory settingD Nash, P E Windt, A M PetersonPharmacoeconomics|October 5, 1994
Infection after surgery for gastrointestinal cancer. Assessing the costsS R NorrbyPharmacoeconomics|November 4, 1994
Cost effectiveness of antiviral treatment with zalcitabine plus zidovudine for AIDS patients with CD4+ counts less than 300/microliters in 5 European countriesK Simpson, E J Hatziandreu, F Andersson, et al.Pageof 335